Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 0

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-284350

PROSPECTUS

<div align='center'>358,750,000,000 Ordinary Shares Representing 35,875,000 American Depositary Shares

___________________</div>

This prospectus relates to
the potential offer and sale from time to time by C/M Capital Master Fund, LP, or the Selling Shareholder, of up to 358,750,000,000 of
our ordinary shares, nominal value £0.00005 per share, or Ordinary Shares, represented by 35,875,000 American Depositary Shares, or Depositary Shares, that have been or may be issued by us to the Selling Shareholder
pursuant to a Securities Purchase Agreement, dated as of January 17, 2025, by and between us and C/M, or the Purchase Agreement, establishing
an equity line of credit, or the Equity Financing. Such Depositary Shares include (a) 35,000,000 Depositary Shares, or the Purchase Shares,
underlying 350,000,000,000 Ordinary Shares by that we may elect, in our sole discretion, to issue and sell to the Selling Shareholder,
from time to time from and after the Commencement Date (as defined herein) under the Purchase Agreement, and subject to applicable stock
exchange rules (assuming the shares to be issued and sold at a price of $1.00 per share) and (b) up to 875,000 Depositary Shares, or the
Commitment Shares, underlying 8,750,000,000 Ordinary Shares that may be issued to the Selling Shareholder to release the Company of its
liability to pay the Commitment Fee (as defined herein) as consideration for it entering into the Purchase Agreement (assuming the shares
to be issued at a price of $1.00 per share).

The actual number of shares
issuable will vary depending on the then-current market price of our Depositary Shares sold to the Selling Shareholder under the Purchase
Agreement, but will not exceed the number set forth in the preceding sentences unless we file an additional registration statement under
the Securities Act of 1933, as amended, or the Securities Act, with the Securities and Exchange Commission, or SEC. See “The Committed Equity Financing” for a description of the Purchase Agreement and “Selling Shareholder” for additional
information regarding the Selling Shareholder.

We are not selling any securities